Pharma marketing has historically lacked a unified infrastructure, unlike finance, HR, and sales, leading to fragmented data and distrust in campaign effectiveness. Despite significant spending, a lack of a foundational layer connecting decisions and providing a shared operational reality has resulted in wasted budgets and inefficiencies. However, the convergence of AI-driven intelligence, a new generation of marketing leaders, and increased competitive pressure may finally enable pharma marketing to achieve its defining infrastructure moment. AI
IMPACT AI is identified as a key enabler for unifying fragmented pharma marketing operations and improving decision-making.
RANK_REASON Article discusses industry trends and potential future shifts without announcing a specific event.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
